ANI Pharmaceuticals, Inc. FDA Record
- Latest inspection VAI · Dec 6, 2024
- No warning letters matched by name
ANI Pharmaceuticals, Inc. has 13 FDA recalls, 10 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "ANI Pharmaceuticals, Inc." is on file.
- Latest recall
- D-0619-2026 · Class III · Jun 2, 2026
- Latest inspection
- Dec 6, 2024 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 13 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 10 | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
ANI Pharmaceuticals, Inc.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 2 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 1 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 1 | 0 | 0 | 5 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 6 | 0 |
| 2019 | 1 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing ANI Pharmaceuticals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check ANI Pharmaceuticals, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0619-2026 | Class III | hydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL (1 Pint), Rx only, Distributed by… | Jun 2, 2026 |
| D-0543-2026 | Class II | Estradiol Gel, 0.1%, 0.25 mg, 0.25 g per packet, 30 packets per carton, Rx only, Distributed by: ANI… | May 12, 2026 |
| D-0564-2022 | Class II | Alprazolam Tablets, USP 0.25 mg, packaged in a) 100-count bottles (NDC 67253-900-10), b) 500-count… | Feb 15, 2022 |
| D-0567-2022 | Class II | Alprazolam Tablets, USP 2.0 mg, packaged in a) 100-count bottles (NDC 67253-903-10), b) 500-count… | Feb 15, 2022 |
| D-0568-2022 | Class II | Pyrazinamide Tablets, USP 500 mg, 100-count bottles, Rx only, Manufactured by: ULTRAtab… | Feb 15, 2022 |
| D-0566-2022 | Class II | Alprazolam Tablets, USP 1.0 mg, packaged in a) 100-count bottles (NDC 67253-902-10), b) 500-count… | Feb 15, 2022 |
| D-0565-2022 | Class II | Alprazolam Tablets, USP 0.5 mg, packaged in a) 100-count bottles (NDC 67253-901-10), b) 500-count… | Feb 15, 2022 |
| D-0044-2021 | Class III | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and… | Oct 9, 2020 |
| D-0047-2021 | Class III | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and… | Oct 9, 2020 |
| D-0048-2021 | Class III | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and… | Oct 9, 2020 |
| D-0046-2021 | Class III | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and… | Oct 9, 2020 |
| D-0045-2021 | Class III | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and… | Oct 9, 2020 |
| D-0043-2021 | Class III | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and… | Oct 9, 2020 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Dec 6, 2024 | Baudette, MN | Drugs | Voluntary Action Indicated (VAI) | 2111358 |
| Nov 18, 2022 | Baudette, MN | Drugs | Voluntary Action Indicated (VAI) | 2111358 |
| Apr 12, 2019 | Baudette, MN | Drugs | No Action Indicated (NAI) | 2111358 |
| Jul 28, 2016 | Baudette, MN | Drugs | No Action Indicated (NAI) | 2111358 |
| Sep 27, 2013 | Baudette, MN | Drugs | No Action Indicated (NAI) | 2111358 |
| Jan 6, 2012 | Baudette, MN | Drugs | Voluntary Action Indicated (VAI) | 2111358 |
| Sep 16, 2011 | Baudette, MN | Drugs | Voluntary Action Indicated (VAI) | 2111358 |
| Sep 15, 2011 | Baudette, MN | Drugs | No Action Indicated (NAI) | 2111358 |
| Jan 29, 2010 | Baudette, MN | Drugs | Voluntary Action Indicated (VAI) | 2111358 |
| Jan 28, 2010 | Baudette, MN | Drugs | No Action Indicated (NAI) | 2111358 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 2111358 | Baudette, MN | 10 | Dec 6, 2024 |
ANI Pharmaceuticals, Inc. and the FDA: common questions
Has ANI Pharmaceuticals, Inc. received an FDA warning letter?
No FDA warning letter addressed to the name "ANI Pharmaceuticals, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has ANI Pharmaceuticals, Inc. received an FDA Form 483?
FDA has not published a Form 483 for "ANI Pharmaceuticals, Inc." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect ANI Pharmaceuticals, Inc.?
The most recent FDA inspection on file ended Dec 6, 2024 at Baudette, MN and was classified VAI. FDA has 10 inspections of ANI Pharmaceuticals, Inc. on file.
Has ANI Pharmaceuticals, Inc. had an FDA recall?
Yes. ANI Pharmaceuticals, Inc. has 13 FDA recalls on record. The most recent started Jun 2, 2026.
Need more than this page shows? Ask about ANI Pharmaceuticals, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.